/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the US and internationally. With a market cap of $39.6 billion, ResMed operates through Sleep and Breathing Health and Residential Care Software segments.
Companies worth $10 billion or more are generally described as "large-cap stocks." RMD fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical instruments & supplies industry.